Clinical Trial Update: Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating upfront hematopoietic stem cell transplantation in adults aged 65-75 with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Acute Myeloid Leukemia, Adult | Phase 2 | Status: COMPLETED